+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risk factors for the acquisition of colistin and carbapenem-resistant Klebsiella pneumoniae in Medelln-Colombia, an endemic region for carbapenem resistance



Risk factors for the acquisition of colistin and carbapenem-resistant Klebsiella pneumoniae in Medelln-Colombia, an endemic region for carbapenem resistance



International Journal of Infectious Diseases 53: 39-40




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 064909011

Download citation: RISBibTeXText

DOI: 10.1016/j.ijid.2016.11.106


Related references

Retraction. Characterization of carbapenem resistance mechanisms and in vitro synergistic activity of colistin plus meropenem in carbapenem resistant Klebsiella pneumoniae. Microbiology and Immunology 59(3): 182-182, 2016

Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias. Bmc Infectious Diseases 17(1): 203, 2017

Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. American Journal of Infection Control 40(5): 421-425, 2012

Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveillance 19(42), 2015

Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp). Journal of Infection 74(1): 103-106, 2016

Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microbial Drug Resistance 11(2): 165-169, 2005

Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae. Southern Medical Journal 104(2): 106-110, 2011

A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients. Journal of Infection in Developing Countries 10(3): 208-213, 2016

Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?. Clinical Infectious Diseases 65(4): 702-703, 2017

The threat of colistin resistance among carbapenem-resistant Klebsiella pneumoniae isolates in Iran. Iranian Journal of Microbiology 10(2): 72-73, 2018

Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae Mediated by Chromosomal Integration of Plasmid DNA. Antimicrobial Agents and ChemoTherapy 61(8), 2017

Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality. Clinical Infectious Diseases 64(6): 711-718, 2016

High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clinical Microbiology and Infection 19(1): E23-E30, 2013

Evaluation of ComASP™ Colistin (formerly SensiTest™ Colistin), a commercial broth microdilution-based method to evaluate the colistin minimum inhibitory concentration for carbapenem-resistant Klebsiella pneumoniae isolates. Journal of Global Antimicrobial Resistance 15: 123-126, 2018

Carbapenem-Resistant Klebsiella pneumoniae: Results of a Laboratory Surveillance Program in an Italian General Hospital (August 2014-January 2015) : Surveillance of Carbapenem-resistant Klebsiella pneumoniae. Advances in Experimental Medicine and Biology 901: 91-101, 2017